Facts About phenobarbital interactions Revealed
On initiation or discontinuation of guselkumab in patients who are getting concomitant CYP450 substrates, especially Those people with a narrow therapeutic index, consider monitoring for therapeutic effect.フェニトインやカルバマゼピン、バルプロ酸など他の抗てんかん薬と同様に葉酸の吸収や代謝に影響し、貧